Ellen B. Richstone - 29 Nov 2022 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role: Director
Signature: /s/ Lisa Ricciardi, Attorney-in-Fact
Issuer symbol: CGTX
Transactions as of: 29 Nov 2022
Net transactions value: +$26,550
Form type: 4
Filing time: 29 Nov 2022, 15:57:01 UTC
Previous filing: 10 Jun 2022
Next filing: 02 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CGTX	Common Stock	Purchase	$26,550	+10,000		$2.66	10,000	29 Nov 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the weighted average purchase price. The shares were purchased at prices ranging from $2.61 to $2.67 per share. The reporting person undertakes to provide to Cognition Therapeutics, Inc., any security holder of Cognition Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

Represents the weighted average purchase price. The shares were purchased at prices ranging from $2.61 to $2.67 per share. The reporting person undertakes to provide to Cognition Therapeutics, Inc., any security holder of Cognition Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.